A study introduced at SNM's 58th Annual Meeting may lead to the next wave of cancer imaging by helping to develop a molecular imaging agent that detects many malignant cancers' incessant development of blood vesselsa process called angiogenesis. A protein biomarker known as CD105 has been shown to indicate tumor angiogenesis in cancer patients.
- New molecular imaging agent targets cornerstone of cancerous tumorsMon, 6 Jun 2011, 13:38:56 EDT
- Molecular imaging 'probes' pinpoint prostate cancerMon, 7 Jun 2010, 14:15:12 EDT
- Novel imaging agent targets breast tumor developmentMon, 6 Jun 2011, 13:39:07 EDT
- Combined imaging agents advance PET imaging of cancerMon, 6 Jun 2011, 13:38:39 EDT
- Molecular imaging detects recurrent prostate cancerMon, 7 Jun 2010, 0:25:24 EDT